Fertility and Sterility/LinkedIn
Feb 2, 2026, 13:04
Optimal GnRH Agonist Dosage for Oocyte Maturation – Fertility and Sterility
Fertility and Sterility shared a post on LinkedIn:
“Optimal gonadotropin-releasing hormone agonist dosage for oocyte maturation in low-prognosis patients: Interim analysis of a randomized controlled trial
Title: Optimal gonadotropin-releasing hormone agonist dosage for oocyte maturation in low-prognosis patients: interim analysis of a randomized controlled trial in Patient-Oriented Strategies Encompassing IndividualizeD Oocyte groups 3 and 4
Authors: Anjali Gahlan, Matheus Roque, Akanksha Jangid, Amrita Das, Pawan Yadav, Shashank Sangoudar, Kshitiz Murdia, Amol Lunkad, Vipin Chandra, Nitiz Murdia, Isha Suwalka, Walmik Mistari

Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Mar 21, 2026, 19:55Rebecca Mallick: Fertility Must Become Standard in Endometriosis Care
-
Mar 21, 2026, 19:48Kendra Batchelder: The Momentum Behind Women’s Health Innovation
-
Mar 21, 2026, 19:44COVID-19 Vaccination During Pregnancy in 2026 – Weence Health Content Services
-
Mar 21, 2026, 19:37Endometriosis and the Endocannabinoid System – ANTG
-
Mar 21, 2026, 19:35Corina Carpenter: A Guide to Clinical Trial Compensation in San Antonio
-
Mar 21, 2026, 19:31The Signals Behind PCOS – PCOS Awareness Association
-
Mar 21, 2026, 19:26Paternal Impact on Embryo Morphokinetics and ART Success – RBMO
-
Mar 21, 2026, 19:19Christopher Robinson: Maternal Fetal Pharmacokinetics of Azithromycin in Preterm Premature Rupture of Membranes
-
Mar 21, 2026, 19:13Lori Brumat: Why Women’s Health Should Matter to Everyone Right Now
